Search Results - "Rodriguez Lescure, A."

The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER) by Aapro, M., Molassiotis, A., Dicato, M., Peláez, I., Rodríguez-Lescure, Á., Pastorelli, D., Ma, L., Burke, T., Gu, A., Gascon, P., Roila, F.

“…While guidelines for preventing chemotherapy-induced nausea and vomiting (CINV) are widely available, clinical uptake of guidelines remains low. Our objective…”
Get full text

Multidisciplinary consensus on cancer management during pregnancy by Cubillo, A., Morales, S., Goñi, E., Matute, F., Muñoz, J. L., Pérez-Díaz, D., de Santiago, J., Rodríguez-Lescure, Á.

“…Cancer during pregnancy is a challenge for multi- and interdisciplinary collaboration due to the diagnostic, prognostic and therapeutic implications, the need…”
Get full text

Multidisciplinary consensus on the criteria for fertility preservation in cancer patients by Santaballa, A., Márquez-Vega, C., Rodríguez-Lescure, Á., Rovirosa, Á., Vázquez, L., Zeberio-Etxetxipia, I., Andrés, M., Bassas, L., Ceballos-Garcia, E., Domingo, J., Manau-Trullas, D.

“…Infertility is one of the main sequelae of cancer and its treatment in both children and adults of reproductive age. It is, therefore, essential that…”
Get full text

Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology by Remon, J., García-Campelo, R., de Álava, E., Vera, R., Rodríguez-Peralto, J. L., Rodríguez-Lescure, Á., Bellosillo, B., Garrido, P., Rojo, F., Álvarez-Alegret, R.

“…The proportion of cancer patients with tumours that harbour a potentially targetable genomic alteration is growing considerably. The diagnosis of these genomic…”
Get full text

Study of the Spanish Society of Medical Oncology (SEOM) on the access to oncology drugs and predictive biomarkers in Spain by Rodríguez-Lescure, A., de la Peña, F. A., Aranda, E., Calvo, A., Felip, E., Garrido, P., Vera, R.

“…Purpose The Spanish Society of Medical Oncology (SEOM) has carried out a study to analyse the conditions of access to oncology drugs in clinical practice in…”
Get full text

Impact of the COVID-19 pandemic on the care of cancer patients in Spain by Amador, M., Matias-Guiu, X., Sancho-Pardo, G., Contreras Martinez, J., de la Torre-Montero, J.C., Peñuelas Saiz, A., Garrido, P., García-Sanz, R., Rodríguez-Lescure, Á., Paz-Ares, L.

“…Studies evaluating the effects of the COVID-19 pandemic on public healthcare systems are limited, particularly in cancer management. As no such studies have…”
Get full text

2019 SEOM guidelines (the end of a decade) by González-del-Alba, A., Rodríguez-Lescure, Á.

Get full text

Future care for long-term cancer survivors: towards a new model by Provencio, M., Romero, N., Tabernero, J., Vera, R., Baz, D. V., Arraiza, A., Camps, C., Felip, E., Garrido, P., Gaspar, B., Llombart, M., López, A., Magallón, I., Ibáñez, V. M., Olmos, J. M., Mur, C., Navarro-Ruiz, A., Pastor, A., Peiró, M., Polo, J., Rodríguez-Lescure, Á.

“…Purpose The increase in the prevalence "long-term cancer survivor” (LCS) patients is expected to increase the cost of LCS care. The aim of this study was to…”
Get full text

Prognostic role for the derived neutrophil-to-lymphocyte ratio in early breast cancer: a GEICAM/9906 substudy by Templeton, A. J., Rodríguez-Lescure, Á., Ruíz, A., Alba, E., Calvo, L., Ruíz-Borrego, M., Santaballa, A., Rodríguez, C. A., Crespo, C., Ramos, M., Gracia-Marco, J. M., Lluch, A., Álvarez, I., Casas, M. I., Sánchez-Aragó, M., Caballero, R., Carrasco, E., Amir, E., Martin, M., Ocaña, A.

“…Purpose Elevated markers of host inflammation, a hallmark of cancer, have been associated with worse outcomes in several solid tumors. Here, we explore the…”
Get full text

Advanced breast cancer clinical nursing curriculum: review and recommendations by Vila, C., Reñones, C., Ferro, T., Peñuelas, Mª. Á., del Mar Jiménez, M., Rodríguez-Lescure, Á., Muñoz, M., Colomer, R.

“…Purpose The needs and concerns of patients with advanced breast cancer are changing at every phase of the care intervention. Management and coordination of…”
Get full text

A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study by Gavilá, J., De La Haba, J., Bermejo, B., Rodríguez-Lescure, Á., Antón, A., Ciruelos, E., Brunet, J., Muñoz-Couselo, E., Santisteban, M., Rodríguez Sánchez, C. A., Santaballa, A., Sánchez Rovira, P., García Sáenz, J. Á., Ruiz-Borrego, M., Guerrero-Zotano, A. L., Huerta, M., Cotes-Sanchís, A., Lao Romera, J., Aguirre, E., Cortés, J., Llombart-Cussac, A.

“…Purpose To evaluate the efficacy and safety of lapatinib (L) and trastuzumab (T) combination in HER2-positive metastatic breast cancer (MBC) patients…”
Get full text

Identifying and preventing burnout in young oncologists, an overwhelming challenge in the COVID-19 era: a study of the Spanish Society of Medical Oncology (SEOM) by Jiménez-Labaig, P., Pacheco-Barcia, V., Cebrià, A., Gálvez, F., Obispo, B., Páez, D., Quílez, A., Quintanar, T., Ramchandani, A., Remon, J., Rogado, J., Sánchez, D.A., Sánchez-Cánovas, M., Sanz-García, E., Sesma, A., Tarazona, N., Cotés, A., González, E., Bosch-Barrera, J., Fernández, A., Felip, E., Vera, R., Rodríguez-Lescure, Á., Élez, E.

“…Young oncologists are at particular risk of professional burnout, and this could have a significant impact on their health and care of their patients. The…”
Get full text

Gender influence on work satisfaction and leadership for medical oncologists: a survey of the Spanish Society of Medical Oncology (SEOM) by Elez, E., Ayala, F., Felip, E., García Campelo, R., García Carbonero, R., García Donás, J., González del Alba, A., González Flores, E., Hidalgo, J., Isla, D., Majem, M., Rodríguez Lescure, Á., Safont, M.J., Santaballa, A., Villacampa, G., Vera, R., Garrido, P.

“…Women represent an increasing proportion of the oncology workforce; however, globally this does not translate into leadership roles, reflecting disparities in…”
Get full text

Epirubicin–cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently versus sequentially: randomized phase III trial in postmenopausal node-positive breast cancer patients. A GEICAM 9401 study by Pico, C., Martin, M., Jara, C., Barnadas, A., Pelegri, A., Balil, A., Camps, C., Frau, A., Rodriguez-Lescure, A., Lopez-Vega, J. M., de la Haba, J., Tres, A., Alvarez, I., Alba, E., Arcusa, A., Oltra, A., Batista, N., Checa, T., Perez-Carrion, R., Curto, J.

“…Background: A prospective randomized clinical trial was implemented to assess whether the concomitant or the sequential addition of tamoxifen to chemotherapy…”
Get full text

Gestational breast cancer: distinctive molecular and clinico-epidemiological features by de la Haba-Rodríguez, J. R., Mínguez, P., Rojo, F., Martín, M., Alba, E., Servitja, S., Prat, A., Pérez-Fidalgo, J. A., Gavilá, J., Morales, C., Rodriguez-Lescure, A., Herrero, C., Peña-Enriquez, R, Herranz, J., Hernando, C., Hernández-Blanquisett, A., Guil-Luna, S., Martinez, MT, Blanch, S., Caballero, R., Martín, N., Pollán, M., Guerrero-Zotano, A., Bermejo, B.

“…Gestational breast cancer (GBC), defined as breast cancer (BC) diagnosed during pregnancy or the first-year post-partum, accounts for 6–15% of BC cases in…”
Get full text

Outcomes of single versus double hormone receptor–positive breast cancer. A GEICAM/9906 sub-study by Ethier, J.L., Ocaña, A., Rodríguez Lescure, A., Ruíz, A., Alba, E., Calvo, L., Ruíz-Borrego, M., Santaballa, A., Rodríguez, C.A., Crespo, C., Ramos, M., Gracia Marco, J., Lluch, A., Álvarez, I., Casas, M., Sánchez-Aragó, M., Carrasco, E., Caballero, R., Amir, E., Martin, M.

“…Retrospective data suggest better outcomes for patients with double hormonal receptor (oestrogen [ER] and progesterone receptor [PgR])–positive (dHR+) early…”
Get full text

Randomized Phase 3 Trial of Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer by Martín, Miguel, Rodríguez-Lescure, Álvaro, Ruiz, Amparo, Alba, Emilio, Calvo, Lourdes, Ruiz-Borrego, Manuel, Munárriz, Blanca, Rodríguez, César A., Crespo, Carmen, de Alava, Enrique, López García-Asenjo, José Antonio, Guitián, María Dolores, Almenar, Sergio, González-Palacios, Jesús Fernando, Vera, Francisco, Palacios, José, Ramos, Manuel, Gracia Marco, Jose Manuel, Lluch, Ana, Alvarez, Isabel, Seguí, Miguel Angel, Mayordomo, José Ignacio, Antón, Antonio, Baena, José Manuel, Plazaola, Arrate, Modolell, Alfonso, Pelegrí, Amadeu, Mel, Jose Ramón, Aranda, Enrique, Adrover, Encarna, Álvarez, José Valero, García Puche, José Luis, Sánchez-Rovira, Pedro, Gonzalez, Sonia, López-Vega, José Manuel

“…Background Taxanes are among the most active drugs for the treatment of metastatic breast cancer, and, as a consequence, they have also been studied in the…”
Get full text

Situation, challenges, and SEOM recommendations for the future of undergraduate education in Oncology in Spain by Segui, M. A., Cruz, J. J., Alba, E., Feliu, J., Jara, C., Rivera, F., Rodriguez Lescure, A., Lorenzo, A., Martin, M.

“…Purpose The Spanish Society of Medical Oncology (SEOM, for its Spanish acronym) would like to attest to the relevance of training in Oncology as part of the…”
Get full text

TESEO, cancer-associated thrombosis registry from the Spanish Society of Medical Oncology (SEOM) by Muñoz Martín, A. J., Jiménez-Fonseca, P., Carmona-Bayonas, A., Martínez de Castro, E., Muñoz Langa, J., Pérez Segura, P., Rodríguez Lescure, A., Vera García, R.

Get full text

RsaI polymorphism at the cytochrome P4502E1 locus and risk of hepatocellular carcinoma by Ladero, J M, Agúndez, J A, Rodríguez-Lescure, A, Diaz-Rubio, M, Benítez, J

“…BACKGROUND: CYP2E1, the coding gene for the ethanol inducible cytochrome P4502E1, is polymorphic at the RsaI restriction site in the 5' flanking region. The…”
Get full text